Latest news
China approval for TransThera’s Yochanra - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 19:24:48 GMTChina approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 13:02:10 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Fri, 07 Aug 2026 12:25:36 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 11:50:30 GMTYochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 07:00:01 GMTTransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma - TipRanksTipRanks · Fri, 07 Aug 2026 05:38:49 GMTTransThera Biosciences' First Drug Jentaia Approved for Market in China, Shares Surge Nearly 15% - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 01:55:00 GMTTransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSciAllSci · Thu, 06 Aug 2026 16:41:13 GMT